Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis

Pathogenesis and pathophysiology of endometriosis

(2012) Richard O. Burney et al.   FERTILITY AND STERILITY

Growth mechanisms of endometriotic cells in implanted places: a review

(2012) Qiao-Ying Jiang et al.   GYNECOLOGICAL ENDOCRINOLOGY

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

(2012) Celeste Leigh Pearce et al.   LANCET ONCOLOGY

Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer

(2011) T. V. Clendenen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations

(2011) Peter Svenssen Munksgaard et al.   GYNECOLOGIC ONCOLOGY

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

(2011) Sohei Yamamoto et al.   MODERN PATHOLOGY

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

(2011) Michael P. Stany et al.   PLoS One

Modulation of estrogenic action in clear cell carcinoma of the ovary (Review)

(2011) YASUHITO TANASE et al.   Experimental and Therapeutic Medicine

Prognostic analysis of ovarian cancer associated with endometriosis

(2010) Sanjeev Kumar et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Endometriosis and ovarian cancer: A review

(2010) Nikos F. Vlahos et al.   GYNECOLOGICAL ENDOCRINOLOGY

The Role of Hepatocyte Nuclear Factor-1β in the Pathogenesis of Clear Cell Carcinoma of the Ovary

(2010) Hiroshi Kobayashi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer

(2009) Nikos F. Vlahos et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer

(2009) P. Liu et al.   CANCER RESEARCH

Theoretical model of treatment strategies for clear cell carcinoma of the ovary: Focus on perspectives

(2009) Shozo Yoshida et al.   CANCER TREATMENT REVIEWS

The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer

(2009) Constanze Banz et al.   FERTILITY AND STERILITY

The role of iron in the pathogenesis of endometriosis

(2009) Hiroshi Kobayashi et al.   GYNECOLOGICAL ENDOCRINOLOGY

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

(2009) Masaki Mandai et al.   International Journal of Clinical Oncology

Hormone Therapy and Ovarian Cancer

(2009) Lina Steinrud Mørch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Endometriosis

(2009) Serdar E. Bulun   NEW ENGLAND JOURNAL OF MEDICINE

Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery

(2008) Mary Anne Rossing et al.   CANCER CAUSES & CONTROL

Loss of estrogen receptor β isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma

(2008) Fumihiko Suzuki et al.   CANCER SCIENCE

Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress

(2008) K. Yamaguchi et al.   CLINICAL CANCER RESEARCH

The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress

(2008) Jorge Limón-Pacheco et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS